Genomic tools such as next-generation sequencing (NGS) and microarrays allow scientists to examine the genetic alterations in cancer cells. NGS, for example, can identify mutations, copy number variations, and gene fusions at a high resolution. These tools are essential for understanding the genetic basis of cancer and for the development of targeted therapies.
